Cargando…

Developmental Abnormalities, Blood Pressure Variability and Renal Disease In Riley Day Syndrome

Riley Day syndrome, commonly referred to as familial dysautonomia (FD), is a genetic disease with extremely labile blood pressure due to baroreflex deafferenation. Chronic renal disease is very frequent in these patients and was attributed to recurrent arterial hypotension and renal hypoperfusion. A...

Descripción completa

Detalles Bibliográficos
Autores principales: Norcliffe-Kaufmann, Lucy, Axelrod, Felicia B., Kaufmann, Horacio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3318957/
https://www.ncbi.nlm.nih.gov/pubmed/22129610
http://dx.doi.org/10.1038/jhh.2011.107
_version_ 1782228714773282816
author Norcliffe-Kaufmann, Lucy
Axelrod, Felicia B.
Kaufmann, Horacio
author_facet Norcliffe-Kaufmann, Lucy
Axelrod, Felicia B.
Kaufmann, Horacio
author_sort Norcliffe-Kaufmann, Lucy
collection PubMed
description Riley Day syndrome, commonly referred to as familial dysautonomia (FD), is a genetic disease with extremely labile blood pressure due to baroreflex deafferenation. Chronic renal disease is very frequent in these patients and was attributed to recurrent arterial hypotension and renal hypoperfusion. Aggressive treatment of hypotension, however, has not reduced its prevalence. We evaluated the frequency of kidney malformations as well as the impact of hypertension, hypotension and blood pressure variability on the severity of renal impairment. We also investigated the effect of fludrocortisone treatment on the progression of renal disease. Patients with FD appeared to have an increased incidence of hydronephrosis/reflux and patterning defects. Patients younger than 4 years old had hypertension and normal eGFR. Patients with more severe hypertension and greater variability in their blood pressure had worse renal function (both, p<0.01). In contrast, there was no relationship between eGFR and the lowest blood pressure recorded during upright tilt. The progression of renal disease was faster in patients receiving fludrocortisone (p<0.02). Hypertension precedes kidney disease in these patients. Moreover, increased blood pressure variability as well as mineralocorticoid treatment accelerate the progression of renal disease. No association was found between hypotension and renal disease in patients with FD.
format Online
Article
Text
id pubmed-3318957
institution National Center for Biotechnology Information
language English
publishDate 2011
record_format MEDLINE/PubMed
spelling pubmed-33189572013-07-01 Developmental Abnormalities, Blood Pressure Variability and Renal Disease In Riley Day Syndrome Norcliffe-Kaufmann, Lucy Axelrod, Felicia B. Kaufmann, Horacio J Hum Hypertens Article Riley Day syndrome, commonly referred to as familial dysautonomia (FD), is a genetic disease with extremely labile blood pressure due to baroreflex deafferenation. Chronic renal disease is very frequent in these patients and was attributed to recurrent arterial hypotension and renal hypoperfusion. Aggressive treatment of hypotension, however, has not reduced its prevalence. We evaluated the frequency of kidney malformations as well as the impact of hypertension, hypotension and blood pressure variability on the severity of renal impairment. We also investigated the effect of fludrocortisone treatment on the progression of renal disease. Patients with FD appeared to have an increased incidence of hydronephrosis/reflux and patterning defects. Patients younger than 4 years old had hypertension and normal eGFR. Patients with more severe hypertension and greater variability in their blood pressure had worse renal function (both, p<0.01). In contrast, there was no relationship between eGFR and the lowest blood pressure recorded during upright tilt. The progression of renal disease was faster in patients receiving fludrocortisone (p<0.02). Hypertension precedes kidney disease in these patients. Moreover, increased blood pressure variability as well as mineralocorticoid treatment accelerate the progression of renal disease. No association was found between hypotension and renal disease in patients with FD. 2011-12-01 2013-01 /pmc/articles/PMC3318957/ /pubmed/22129610 http://dx.doi.org/10.1038/jhh.2011.107 Text en Users may view, print, copy, download and text and data- mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms
spellingShingle Article
Norcliffe-Kaufmann, Lucy
Axelrod, Felicia B.
Kaufmann, Horacio
Developmental Abnormalities, Blood Pressure Variability and Renal Disease In Riley Day Syndrome
title Developmental Abnormalities, Blood Pressure Variability and Renal Disease In Riley Day Syndrome
title_full Developmental Abnormalities, Blood Pressure Variability and Renal Disease In Riley Day Syndrome
title_fullStr Developmental Abnormalities, Blood Pressure Variability and Renal Disease In Riley Day Syndrome
title_full_unstemmed Developmental Abnormalities, Blood Pressure Variability and Renal Disease In Riley Day Syndrome
title_short Developmental Abnormalities, Blood Pressure Variability and Renal Disease In Riley Day Syndrome
title_sort developmental abnormalities, blood pressure variability and renal disease in riley day syndrome
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3318957/
https://www.ncbi.nlm.nih.gov/pubmed/22129610
http://dx.doi.org/10.1038/jhh.2011.107
work_keys_str_mv AT norcliffekaufmannlucy developmentalabnormalitiesbloodpressurevariabilityandrenaldiseaseinrileydaysyndrome
AT axelrodfeliciab developmentalabnormalitiesbloodpressurevariabilityandrenaldiseaseinrileydaysyndrome
AT kaufmannhoracio developmentalabnormalitiesbloodpressurevariabilityandrenaldiseaseinrileydaysyndrome